Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 5

Impact of bronchodilator therapy on exercise tolerance in COPD

Authors B Aguilaniu

Published 9 March 2010 Volume 2010:5 Pages 57—71

DOI https://doi.org/10.2147/COPD.S7404

Review by Single-blind

Peer reviewer comments 3

B Aguilaniu

HYLAB, Laboratory of Clinical Physiology and Exercise, Grenoble, France

Abstract: Exercise tolerance is an important parameter in patients with COPD and a primary goal of treatment is to reduce dyspnea to facilitate physical activities and improve health-related quality of life. This review examines the link between expiratory flow limitation and dyspnea to explain the rationale for the use of bronchodilators and review the characteristics of different types of exercise tests, with specific focus on which tests are likely to show a response to bronchodilators. An earlier literature search of studies published up to 1999 assessed the effects of bronchodilator therapy on dypsnea and exercise tolerance among patients with COPD. This current review examines the clinical evidence published since 1999. Thirty-one randomized studies of exercise tolerance associated with short- and long-acting β2-agonists and anticholinergics were identified. Evidence for the efficacy of bronchodilators in enhancing exercise capacity is often contradictory and possibly depends on the exercise test and study methodology. However, further studies should confirm the benefit of long-acting bronchodilators in improving spontaneous everyday physical activities.
Keywords: COPD, exercise, bronchodilator, walk test, exercise test

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Readers of this article also read:

Improving adherence with inhaler therapy in COPD

Suzanne C Lareau, Barbara P Yawn

International Journal of Chronic Obstructive Pulmonary Disease 2010, 5:401-406

Published Date: 24 November 2010

Tiotropium Respimat® improves physical functioning in chronic obstructive pulmonary disease

Heike Rau-Berger, Harald Mitfessel, Thomas Glaab

International Journal of Chronic Obstructive Pulmonary Disease 2010, 5:367-373

Published Date: 10 October 2010

Interleukin-6 and airflow limitation in chemical warfare patients with chronic obstructive pulmonary disease

Davood Attaran, Shahrzad M Lari, Mohammad Towhidi, et al

International Journal of Chronic Obstructive Pulmonary Disease 2010, 5:335-340

Published Date: 30 September 2010

A day at a time: caregiving on the edge in advanced COPD

A Catherine Simpson, Joanne Young, Margaret Donahue, et al

International Journal of Chronic Obstructive Pulmonary Disease 2010, 5:141-151

Published Date: 10 May 2010

Noninvasive ventilation: has Pandora’s box been opened?

Ari Manuel, Richard EK Russell, Quentin Jones

International Journal of Chronic Obstructive Pulmonary Disease 2010, 5:55-56

Published Date: 24 February 2010

Event-related evoked potentials in chronic respiratory encephalopathy

A R Al Tahan, R Zaidan, S Jones, et al

International Journal of Chronic Obstructive Pulmonary Disease 2010, 5:21-27

Published Date: 5 February 2010